Showing results (451-460 of 1,787) with videos related to

Sort By:
Pageof 179
Hepatology Communications|September 20, 2022
Fatty liver disease reverses the obesity paradox in chronic kidney disease stages 3-5: A follow-up study of NHANES IIIJiaofeng Huang, Min Zhang, Yinlian Wu, et al.
Hepatology Communications|July 6, 2022
The emotional burden of caregiving for patients with cirrhosisZachary M Saleh, Najat E Salim, Samantha Nikirk, et al.
Hepatology Communications|October 7, 2020
Therapeutic Targeting of Myeloperoxidase Attenuates NASH in MiceAnja Christina Koop, Nina Doreen Thiele, David Steins, et al.
Hepatology Communications|May 17, 2022
Combination of tofogliflozin and pioglitazone for NAFLD: Extension to the ToPiND randomized controlled trialMasato Yoneda, Takashi Kobayashi, Yasushi Honda, et al.
Hepatology Communications|October 11, 2023
sTREM2 is a plasma biomarker for human NASH and promotes hepatocyte lipid accumulationVishal Kothari, Christopher Savard, Jingjing Tang, et al.
Hepatology Communications|June 19, 2026
The Transitional Liver Clinic: Study protocol for a stepped-wedge cluster randomized trialLindsay Yoder, Elliot B Tapper, Richard Kalman, et al.
Hepatology Communications|June 19, 2026
Progression of MASH to cirrhosis, decompensation, and mortality, and the utility of NITs for detection and risk stratificationPhilip N Newsome, Claudio Sartini, Heather L Morris, et al.
Hepatology Communications|July 28, 2026
Artificial intelligence predicts recurrent autoimmune hepatitis after liver transplantation in a multicenter cohort studyMamatha Bhat, Yingji Sun, Praveen Manickavel, et al.
Hepatology Communications|August 11, 2026
Liver Point-of-Care Ultrasound (POCUS): Roadmap for training, credentialing, and implementationJose D Debes, Yuko Kono, Amir Gougol, et al.
Hepatology Communications|August 20, 2026
Immune mechanisms and pathophysiology of T cell-mediated pediatric acute liver failure (TC-PALF)Jason T C Lee, Harry Sutton, Priya Pai, et al.
Pageof 179